Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine
OBI Pharma (4174.TWO) announced that it has entered into a commercial...
PromiCell, Inc. (the Company), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the...
Leading regional private healthcare provider group Fullerton Health (“Fullerton Health” or the “Group”) said today it has successfully acquired one of Singapore’s largest otolaryngology...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced the appointment...
TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and the National Association of Pediatric Nurse Practitioners (NAPNAP), The Leader...
Everest Medicines (HKG: 1952) today unveiled its 2030 strategy. Following the announcement, the Company’s shares strengthened during the trading session and briefly reached an...
Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd (Everest Medicines China), has entered into two strategic...
